Summary
79 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 17% a year over the last 3 years.
- Out of every 100 USD of revenue, 9.6 USD is left as net profit.
- It has raised its dividend 9 years in a row and pays out only 41% of profit.
- It earns 8.8 USD a year on every 100 USD of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 15.2 USD for 1 USD of yearly profit. Over the last five years it was 25.1 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 2.8% a year over 5 years. Over the last 3 years it grew by 0.6% a year. For the next fiscal year analysts expect revenue to grow by 5.8%. Earnings per share grew by 17% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 60 USD
- Research and development 2.6 USD
- Sales and administration 25 USD
- Taxes and other 2.9 USD
- Net profit 9.6 USD
Net profit, industry median (Chemicals - Specialty) 5.9 USD
Out of every 100 USD of revenue, 9.6 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 5.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 2.67%
- Paid out of profit
- 41%
- Raised in a row
- 9 years
You receive $2.87 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 21
- Hold 15
- Sell 2
Today's price within the analysts' price targets
The average target of $129.71 is 21% above today's price. 55% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Industrial Coatings 41%
- Performance Coatings 35%
- Global Architectural Coatings 24%
By region
- North America 34%
- EMEA 34%
- Asia Pacific 19%
- Latin America 14%
Industrial Coatings brings in 41% of revenue.
Segments in detail